期刊
EXPERT REVIEW OF CLINICAL PHARMACOLOGY
卷 6, 期 6, 页码 597-599出版社
INFORMA HEALTHCARE
DOI: 10.1586/17512433.2013.841078
关键词
chronic liver disease; fibrosis; hepatic stellate cells; nuclear hormone receptor; vitamin D
资金
- Howard Hughes Medical Institute Funding Source: Medline
- NCI NIH HHS [P30 CA014195, CA014195] Funding Source: Medline
- NHLBI NIH HHS [P01 HL088093, R01 HL105278, HL088093, HL105278] Funding Source: Medline
- NIDDK NIH HHS [DK057978, R24 DK090962, R37 DK057978, DK090962] Funding Source: Medline
- NIEHS NIH HHS [ES010337, P42 ES010337] Funding Source: Medline
...both benchside and bedside studies could move vitamin D receptor- targeted therapies to the center stage of hepatology and pave the way for the development of a new pipeline of vitamin D receptor ligands with therapeutic promise for a wide range of liver disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
